Literature DB >> 9988184

ELISA for the detection of antibodies to Ebola viruses.

T G Ksiazek1, C P West, P E Rollin, P B Jahrling, C J Peters.   

Abstract

EIAs for IgG and IgM antibodies directed against Ebola (EBO) viral antigens have been developed and evaluated using sera of animals and humans surviving infection with EBO viruses. The IgM capture assay detected anti-EBO (subtype Reston) antibodies in the sera of 5 of 5 experimentally infected animals at the time they succumbed to lethal infections. IgM antibodies were also detected in the serum of a human who was infected with EBO (subtype Reston) during a postmortem examination of an infected monkey. The antibody was detectable as early as day 6 after infection in experimentally infected animals and persisted for <90 days. The IgG response was less rapid; however, it persisted for >400 days in 3 animals who survived infection, and it persisted for approximately 10 years after infection in the sera of 2 humans. Although these data are limited by the number of sera available for verification, the IgM assay seems to have great promise as a diagnostic tool. Furthermore the long-term persistence of the IgG antibodies measured by this test strongly suggests that the ELISA will be useful in field investigations of EBO virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988184     DOI: 10.1086/514313

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  98 in total

Review 1.  Filovirus vaccines.

Authors:  Steven B Bradfute; John M Dye; Sina Bavari
Journal:  Hum Vaccin       Date:  2011-06-01

2.  Mechanism of human antibody-mediated neutralization of Marburg virus.

Authors:  Andrew I Flyak; Philipp A Ilinykh; Charles D Murin; Tania Garron; Xiaoli Shen; Marnie L Fusco; Takao Hashiguchi; Zachary A Bornholdt; James C Slaughter; Gopal Sapparapu; Curtis Klages; Thomas G Ksiazek; Andrew B Ward; Erica Ollmann Saphire; Alexander Bukreyev; James E Crowe
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 3.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.

Authors:  Joel G Breman; David L Heymann; Graham Lloyd; Joseph B McCormick; Malonga Miatudila; Frederick A Murphy; Jean-Jacques Muyembé-Tamfun; Peter Piot; Jean-François Ruppol; Pierre Sureau; Guido van der Groen; Karl M Johnson
Journal:  J Infect Dis       Date:  2016-06-29       Impact factor: 5.226

5.  What Ebola tells us about outbreak diagnostic readiness.

Authors:  Mark D Perkins; Mark Kessel
Journal:  Nat Biotechnol       Date:  2015-05       Impact factor: 54.908

6.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

7.  Nipah virus infection in dogs, Malaysia, 1999.

Authors:  James N Mills; Asiah N M Alim; Michel L Bunning; Ong Bee Lee; Kent D Wagoner; Brian R Amman; Patrick C Stockton; Thomas G Ksiazek
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

8.  Immunoglobulin G in Ebola outbreak survivors, Gabon.

Authors:  Nadia Wauquier; Pierre Becquart; Clélia Gasquet; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

9.  Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

Authors:  Jonathan S Towner; Brian R Amman; Tara K Sealy; Serena A Reeder Carroll; James A Comer; Alan Kemp; Robert Swanepoel; Christopher D Paddock; Stephen Balinandi; Marina L Khristova; Pierre B H Formenty; Cesar G Albarino; David M Miller; Zachary D Reed; John T Kayiwa; James N Mills; Deborah L Cannon; Patricia W Greer; Emmanuel Byaruhanga; Eileen C Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W Tappero; Sherif R Zaki; Thomas G Ksiazek; Stuart T Nichol; Pierre E Rollin
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

10.  Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study.

Authors:  Solen Kernéis; Lamine Koivogui; N'Faly Magassouba; Kekoura Koulemou; Rosamund Lewis; Aristide Aplogan; Rebecca F Grais; Philippe J Guerin; Elisabeth Fichet-Calvet
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.